Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Farghly (Assiut, Egypt), A. El-Karn (Assiut, Egypt), M. Sherif (Assiut, Egypt), M. Seddik (Assiut, Egypt), S. Abdelgayed (Assiut, Egypt), M. Abdelghany (Assiut, Egypt). Serum periostin and eotaxin-2 as promising biomarkers in asthmatic smokers.. 1135

Member's Comments

No comment yet.

Related content which might interest you: Serum periostin is not a good biomarker to identify Th2-driven inflammation in COPD Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Serum neopterin and IL-6 as biomarkers in patients with COPD. Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017 The serum YKL-40 is a useful biomarker for asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Cigarette smoking induced elevated CXCL5 levels in BALF and plasma of patients with COPD Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018 Osteopontin expression is increased in serum, BAL and bronchial tissue of asymptomatic smokers Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Visfatin as a possible serum biomarker in COPD Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Serum periostin but not airway POSTN expression is reduced in smokers with asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Osteopontin and IL17 concentration in serum and breath condensates of asthmatic children in Greece Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Age related alterations in sputum and plasma MMP-9 and TIMP-1 levels in healthy non-smokers and smokers Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Cytokine expression in induced sputum in smokers with asthma or COPD and in healthy smokers Source: Eur Respir J 2003; 22: Suppl. 45, 392s Year: 2003 Elevated serum IL-12 and IL-18 levels in patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 424s Year: 2002 Serum G-CSF is a non-invasive biomarker classifying bacterial/neutrophilic COPD exacerbations Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 PP102 – A serum biomarker reflecting human neutrophil elastase degraded calprotectin is elevated in COPD and IPF Source: ERS Lung Science Conference 2021 Year: 2021 Serum and sputum interleukin-8: comparison between normal and allergic asthmatics children Source: Eur Respir J 2003; 22: Suppl. 45, 175s Year: 2003 Serum KL-6, SP-D and MMP-2 as diagnostic biomarkers in asbestosis and silicosis Source: International Congress 2017 – Silicosis has not gone away Year: 2017 Lebrikizumab reduces serum periostin in asthma patients with elevated baseline periostin Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Serum hyaluronate: A new biomarker of passive smoking-induced lung injury in asthmatic patients Source: Annual Congress 2010 - Innovations in the assessment of airway diseases Year: 2010 Plasma TARC concentration may be a useful marker for asthmatic exacerbation in children Source: Eur Respir J 2003; 21: 616-620 Year: 2003 Increased levels of osteopontin in sputum supernatant in smoking asthma Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011